1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells. [electronic resource]
- Molecular immunology May 2010
- 1728-38 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-9142
10.1016/j.molimm.2010.03.004 doi
Acetylation--drug effects Animals Blotting, Western Breast Neoplasms--genetics COS Cells Calcitriol--pharmacology Cell Line, Tumor Chlorocebus aethiops Down-Regulation--genetics Female HeLa Cells Histone Deacetylases--genetics Humans I-kappa B Proteins--genetics NF-KappaB Inhibitor alpha NF-kappa B--genetics NF-kappa B p50 Subunit--genetics Nuclear Receptor Co-Repressor 2--genetics Phosphorylation--drug effects RNA Interference Receptors, Calcitriol--genetics Reverse Transcriptase Polymerase Chain Reaction Transcriptional Activation--drug effects Tumor Necrosis Factor-alpha--pharmacology Vitamins--pharmacology